Gene Logic Inc. (NASDAQ:GLGC) today announced the launch of its Genesis Enterprise System(R) 3.0 Software to address pharmaceutical industry needs to accelerate drug target discovery and more rapidly assess drug candidate safety. The latest software version offers greater flexibility and new tools enabling researchers to efficiently access, organize, and analyze large amounts of gene expression data associated with clinical, experimental and genomics information.
